Meetings - The ASCO Post

This is Part 3 of Personalizing Therapy for Myelofibrosis, a three-part video roundtable series. Scroll down to watch the other videos from this roundtable. In this video, Drs. Andrew Kuykendall, An...

hematologic malignancies

/ Personalizing Therapy for Myelofibrosis

Patient With Ruxolitinib-Treated Myelofibrosis Who Develops Anemia

This is Part 2 of Personalizing Therapy for Myelofibrosis, a three-part video roundtable series. Scroll down to watch the other videos from this roundtable. In this video, Drs. Andrew Kuykendall, An...

hematologic malignancies

/ Personalizing Therapy for Myelofibrosis

Patient With Newly Diagnosed Myelofibrosis and Moderate Anemia

This is Part 1 of Personalizing Therapy for Myelofibrosis, a three-part video roundtable series. Scroll down to watch the other videos from this roundtable. In this video, Drs. Andrew Kuykendall, An...

Personalizing Therapy for Myelofibrosis

Patient With Transfusion-Dependent Myelofibrosis and Severe Thrombocytopenia

Patient With Ruxolitinib-Treated Myelofibrosis Who Develops Anemia

Patient With Newly Diagnosed Myelofibrosis and Moderate Anemia

Study Finds Daratumumab Monotherapy Prevented or Delayed Progression From Smoldering to Active Multiple Myeloma

Study Finds Genetic Changes, Elevated Leukemia Risk in Ground Zero First Responders

MRI First Strategy May Be Safe for Prostate Cancer Detection

Addition of SBRT to Systemic Therapy May Improve Outcomes in Select Patients With Locally Advanced Hepatocellular Carcinoma

Epcoritamab Monotherapy for Pretreated Relapsed or Refractory CLL